European Archives - Page 277 of 1154 - European Medical Journal

Lung Matters: Understanding COPD

Jean Wright, CEO of the COPD Foundation, joins Jonathan Sackier to discuss her transformative journey in healthcare and innovative approaches to managing chronic lung diseases.

NHS must adapt for next wave of advanced therapies, warns ABPI

The NHS has made commendable progress in introducing advanced therapies, but it must accelerate preparations for the next wave.

Machine Learning Model Predicts Outcomes for Renal Replacement Therapy

Researchers have developed a machine learning-based algorithm to predict short-term survival outcomes in critically ill patients undergoing continuous renal replacement therapy.

High Sugar Intake Linked to Premature Ageing in Childhood Cancer Survivors

A recent study has shed light on the concerning link between high sugar consumption and premature aging in adult survivors of childhood cancer.

Non-Invasive Ultrasound for SLD Assessment

This infographic explores how a non-invasive ultrasound-based technique could enhance the assessment of steatotic liver disease.

Tirzepatide Significantly Reduces Mortality and Kidney Risks in Type 2 Diabetes

A recent cohort study has highlighted the potential of tirzepatide to significantly improve clinical outcomes in patients with Type 2 diabetes.

Real-World Type 2 Diabetes Remission Through NHS Diet Programme

Discover how the NHS Type 2 Diabetes Path to Remission (T2DR) programme, has led to significant weight loss and diabetes remission in participants.

A Case of Mauriac Syndrome Caused by Social Inequities in Healthcare: A Call to Action

A 21-year-old female with a history of Type 1 diabetes mellitus (T1DM) with baseline HbA1c ranging from 8.8–12.5%, delayed menarche…

Meeting the growing demand for medical education quizzes

If you want to engage HCPs, you must deliver high-quality medical education. But are all companies taking advantage of interactive quizzes?

Study Uncovers Key Risk Factors for Monoclonal Gammopathy of Undetermined Significance

Research has identified several modifiable risk factors linked to monoclonal gammopathy of undetermined significance, by utilising advanced mass spectrometry techniques.